Advertisement

Topics

Daiichi Pure Chemicals Company Limited Company Profile

16:39 EDT 22nd September 2017 | BioPortfolio

Drug Discovery

Location

3-13-5 Nihombashi Chuo-ku
Tokyo
Tokyo
103
Japan

Contact

Fax: 81 3 3272 0671


News Articles [1207 Associated News Articles listed on BioPortfolio]

FDA Grants Breakthrough Therapy Designation to Daiichi Sankyo’s DS-8201 for HER2-Positive Metastatic Breast Cancer

Tokyo, Japan, Basking Ridge, NJ, and Munich, Germany – (August 29, 2017) – Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the U.S. Food and Drug Administration (F...

Daiichi Sankyo and MD Anderson Collaborate to Accelerate Development of Acute Myeloid Leukemia Therapies

HOUSTON and TOKYO and BASKING RIDGE, N.J., Sept. 14, 2017 /PRNewswire/ — The University of Texas MD Anderson Cancer Center and Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today a...

Pure Steam Generators Market: Drivers, Challenges, Historical and Current Sizes

Pure steam is water that has been heated above 100 degree Celsius and evaporated in such a way that prevents water source entrainment. The pure steam generator is a water treatment system designed for...

Daiichi Sankyo, SBP begin phase 1 trial of DS─1211 in hyealthy volunteers

Daiichi Sankyo Company, Limited and Sanford Burnham Prebys Medical Discovery Institute (SBP) announced the start of a phase 1, first─in─human clinical trial of DS─1211 in healthy volunteers. DS...

Daiichi Sankyo, Boston Pharmaceuticals sign deal for selective RET inhibitor for solid tumors

Daiichi Sankyo and Boston Pharmaceuticals have entered into a worldwide licensing agreement for Daiichi Sankyo's novel RET inhibitor, DS-5010.

Daiichi Sankyo begins phase 3 ENVISAGE─TAVI AF study of once─daily Lixiana to treat patients with AF undergoing TAVI

Daiichi Sankyo Company, Limited, announced that the first patient has been enrolled into the ENVISAGE─TAVI AF study. The multinational, randomized phase 3b study will evaluate a treatment regimen ba...

MD Anderson, Daiichi Sankyo Partner to Develop AML Treatments

The University of Texas MD Anderson Cancer Center and Daiichi Sankyo said today they plan to develop novel therapies for acute myeloid leukemia (AML) through a multi-year collaboration whose value was...

Daiichi Sankyo settles US products liability litigation

Japanese pharma major Daiichi Sankyo (TYO: 4568) and its US subsidiary have agreed to enter into a…

PubMed Articles [657 Associated PubMed Articles listed on BioPortfolio]

A Method for Identifying Prevalent Chemical Combinations in the U.S. Population.

Through the food and water they ingest, the air they breathe, and the consumer products with which they interact at home and at work, humans are exposed to tens of thousands of chemicals, many of whic...

Hyperspectral depth-profiling with deep Raman spectroscopy for detecting chemicals in building materials.

Toxic chemicals inside building materials have long-term harmful effects on human bodies. To prevent secondary damage caused by the evaporation of latent chemicals, it is necessary to detect the chemi...

Effect of evacuation on liver function after the Fukushima Daiichi Nuclear Power Plant accident: The Fukushima Health Management Survey.

The Great East Japan Earthquake and subsequent Fukushima Daiichi Nuclear Power Plant accident caused residents to switch from their normal lives to lives focused on evacuation. We evaluated liver func...

Evaluating the environmental hazard of industrial chemicals from data collected during the REACH registration process.

Registration dossiers for 11,678 industrial chemicals were retrieved from the database of the European Chemicals Agency, of which 3566 provided a numerical entry for the corresponding predicted no eff...

Tertiary Evaluation of the Committed Effective Dose of Emergency Workers That Responded to the Fukushima Daiichi NPP Accident.

In January 2014, Tokyo Electric Power Company (TEPCO) learned that the committed effective dose (CED) for nine emergency workers at the Fukushima Daiichi Nuclear Power Plant accident had been assessed...

Clinical Trials [390 Associated Clinical Trials listed on BioPortfolio]

Pure Red Cell Aplasia in Patients With Chronic Kidney Disease and in Use of Epoetin Alfa

The purpose of this study is to determine occurrence of pure red cell aplasia in a group of participants with chronic renal insufficiency and with resistance criteria to epoetin alfa treat...

Comparative Study of Loxoprofen Sodium Transdermal Patch and Loxonin® Tablets for the Treatment of Acute Trauma

This study evaluates the non-inferiority of the new transdermal patch dosage form containing loxoprofen sodium (100 mg - Daiichi-Sankyo) in comparison with oral Loxonin® (60 mg tablet - D...

A Study to Observe Patients Who Have Developed a More Severe Form of Anemia (Pure Red Cell Aplasia) Which is Associated With the Erythropoietin Treatment for Their Original Anemia

The purpose of this study is to investigate a possible relationship between antibodies to recombinant erythropoietin and the clinical course of Pure Red Cell Anemia (PRCA) in patients curr...

Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago

To continue the comprehensive research program on the epidemiology of cardiovascular and other major chronic diseases, including cancer and diabetes, in four Chicago population cohorts. T...

Breath Test for Chemicals (Volatile Organic Compounds)

Background: - Some types of cancer, like cancer of the esophagus, are difficult to detect at an early stage. A possible detection method involves collecting breath samples to look for che...

Companies [2149 Associated Companies listed on BioPortfolio]

Daiichi Pure Chemicals Company Limited

Drug Discovery

Wako Chemicals USA, Inc

Wako Chemicals USA, Inc. is a wholly owned subsidiary of Wako Pure Chemical Industries, Ltd. of Japan. Wako Pure Chemicals Industries, Ltd., worldly renowned for its high purity chemicals, established...

Pure Via

Pure Via® is an all-natural, zero-calorie sweetener this is made from Rebaudioside A (Reb A), the sweetest, best-tasting part of the stevia leaf. Reb A is generally recognized ...

Daiichi Sankyo Company, Limited

Daiichi Sankyo Company, Limited, established in 2005 after the joint share transfer of two leading century-old Japanese pharmaceutical companies, is continuously generating innovative drugs that e...

DAIICHI SANKYO EUROPE GmbH and SHARE

DAIICHI SANKYO is a global pharmaceutical company that focuses on researching and marketing innovative medications. The company was created in 2005 through the merger of two traditional Japanese e...

More Information about "Daiichi Pure Chemicals Company Limited" on BioPortfolio

We have published hundreds of Daiichi Pure Chemicals Company Limited news stories on BioPortfolio along with dozens of Daiichi Pure Chemicals Company Limited Clinical Trials and PubMed Articles about Daiichi Pure Chemicals Company Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Daiichi Pure Chemicals Company Limited Companies in our database. You can also find out about relevant Daiichi Pure Chemicals Company Limited Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record